| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | complement component C3b binding | 1.15e-07 | 12 | 80 | 4 | GO:0001851 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 8.64e-07 | 188 | 80 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | opsonin binding | 2.83e-06 | 25 | 80 | 4 | GO:0001846 | |
| GeneOntologyMolecularFunction | integrin binding | 6.53e-06 | 175 | 80 | 7 | GO:0005178 | |
| GeneOntologyMolecularFunction | complement binding | 7.89e-06 | 32 | 80 | 4 | GO:0001848 | |
| GeneOntologyMolecularFunction | complement component C3b receptor activity | 1.59e-05 | 2 | 80 | 2 | GO:0004877 | |
| GeneOntologyMolecularFunction | complement component C4b receptor activity | 1.59e-05 | 2 | 80 | 2 | GO:0001861 | |
| GeneOntologyMolecularFunction | complement component C4b binding | 4.74e-05 | 3 | 80 | 2 | GO:0001855 | |
| GeneOntologyMolecularFunction | zinc ion binding | TRIM43B USP13 ADAMTS3 ADAMTS9 TRIM75 CIZ1 ANKIB1 NFXL1 BAZ1B TRIM43 ADAMTS13 ESCO1 MAP3K1 | 5.02e-05 | 891 | 80 | 13 | GO:0008270 |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 1.21e-04 | 120 | 80 | 5 | GO:0004222 | |
| GeneOntologyMolecularFunction | microfibril binding | 2.35e-04 | 6 | 80 | 2 | GO:0050436 | |
| GeneOntologyMolecularFunction | transition metal ion binding | TRIM43B USP13 ADAMTS3 ADAMTS9 TRIM75 CIZ1 ANKIB1 NFXL1 BAZ1B TRIM43 ADAMTS13 MUC2 ESCO1 MAP3K1 | 2.45e-04 | 1189 | 80 | 14 | GO:0046914 |
| GeneOntologyMolecularFunction | acyltransferase activity | TRIM43B ZDHHC21 TRIM75 RNF185 TRAIP BRPF1 ANKIB1 TRIM43 ESCO1 MAP3K1 HERC5 | 2.56e-04 | 775 | 80 | 11 | GO:0016746 |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 2.92e-04 | 145 | 80 | 5 | GO:0004713 | |
| GeneOntologyMolecularFunction | opsonin receptor activity | 4.37e-04 | 8 | 80 | 2 | GO:0001847 | |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | 6.09e-04 | 473 | 80 | 8 | GO:0004842 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | 7.28e-04 | 372 | 80 | 7 | GO:0061630 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 8.30e-04 | 46 | 80 | 3 | GO:0030020 | |
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 8.30e-04 | 46 | 80 | 3 | GO:0004715 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | 1.02e-03 | 512 | 80 | 8 | GO:0019787 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 1.02e-03 | 12 | 80 | 2 | GO:0048407 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 1.08e-03 | 398 | 80 | 7 | GO:0061659 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 1.25e-03 | 200 | 80 | 5 | GO:0008237 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | 1.30e-03 | 532 | 80 | 8 | GO:0016755 | |
| GeneOntologyMolecularFunction | complement receptor activity | 1.40e-03 | 14 | 80 | 2 | GO:0004875 | |
| GeneOntologyMolecularFunction | RNA 7-methylguanosine cap binding | 1.40e-03 | 14 | 80 | 2 | GO:0000340 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 1.68e-03 | 430 | 80 | 7 | GO:0004175 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 2.09e-03 | 709 | 80 | 9 | GO:0016773 | |
| GeneOntologyMolecularFunction | protein kinase activity | 2.75e-03 | 600 | 80 | 8 | GO:0004672 | |
| GeneOntologyMolecularFunction | RNA cap binding | 3.17e-03 | 21 | 80 | 2 | GO:0000339 | |
| GeneOntologyMolecularFunction | kinase activity | 3.44e-03 | 764 | 80 | 9 | GO:0016301 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activator activity | 3.48e-03 | 22 | 80 | 2 | GO:0030297 | |
| GeneOntologyMolecularFunction | growth factor binding | 3.58e-03 | 156 | 80 | 4 | GO:0019838 | |
| GeneOntologyMolecularFunction | virus receptor activity | 4.83e-03 | 85 | 80 | 3 | GO:0001618 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 4.99e-03 | 86 | 80 | 3 | GO:0140272 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase activity | 5.21e-03 | 27 | 80 | 2 | GO:0004709 | |
| GeneOntologyMolecularFunction | protease binding | 6.05e-03 | 181 | 80 | 4 | GO:0002020 | |
| GeneOntologyMolecularFunction | ephrin receptor binding | 7.27e-03 | 32 | 80 | 2 | GO:0046875 | |
| GeneOntologyMolecularFunction | phospholipase binding | 7.27e-03 | 32 | 80 | 2 | GO:0043274 | |
| GeneOntologyMolecularFunction | heparin binding | 7.42e-03 | 192 | 80 | 4 | GO:0008201 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL3A1 ADAMTS19 COL5A2 ADAMTSL1 HMCN1 ADAMTS3 ADAMTS9 ADAMTS13 PLG ADAMTSL3 ADAMTSL2 COL1A1 | 3.06e-08 | 377 | 82 | 12 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL3A1 ADAMTS19 COL5A2 ADAMTSL1 HMCN1 ADAMTS3 ADAMTS9 ADAMTS13 PLG ADAMTSL3 ADAMTSL2 COL1A1 | 3.15e-08 | 378 | 82 | 12 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL3A1 ADAMTS19 COL5A2 ADAMTSL1 HMCN1 ADAMTS3 ADAMTS9 ADAMTS13 PLG ADAMTSL3 ADAMTSL2 COL1A1 | 3.25e-08 | 379 | 82 | 12 | GO:0045229 |
| GeneOntologyBiologicalProcess | complement activation | 8.68e-06 | 70 | 82 | 5 | GO:0006956 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 1.30e-05 | 76 | 82 | 5 | GO:0030199 | |
| GeneOntologyBiologicalProcess | platelet activation | 3.98e-05 | 158 | 82 | 6 | GO:0030168 | |
| GeneOntologyBiologicalProcess | positive regulation of activation of membrane attack complex | 4.67e-05 | 3 | 82 | 2 | GO:0001970 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | COL3A1 EPHB4 CYFIP1 ADAMTS3 EGFR SIPA1L1 SPRY4 SRC FAM83G LTBP2 MAP3K1 CYFIP2 ADAMTSL2 PTK6 COL1A1 | 5.97e-05 | 1186 | 82 | 15 | GO:0007167 |
| GeneOntologyBiologicalProcess | regulation of body fluid levels | 6.45e-05 | 442 | 82 | 9 | GO:0050878 | |
| GeneOntologyBiologicalProcess | biological process involved in symbiotic interaction | 7.74e-05 | 351 | 82 | 8 | GO:0044403 | |
| GeneOntologyBiologicalProcess | blood coagulation | 7.93e-05 | 260 | 82 | 7 | GO:0007596 | |
| GeneOntologyBiologicalProcess | coagulation | 9.14e-05 | 266 | 82 | 7 | GO:0050817 | |
| GeneOntologyBiologicalProcess | regulation of activation of membrane attack complex | 9.32e-05 | 4 | 82 | 2 | GO:0001969 | |
| GeneOntologyBiologicalProcess | hemostasis | 9.58e-05 | 268 | 82 | 7 | GO:0007599 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | COL3A1 CYFIP1 ADAMTS3 EGFR SPRY4 SRC FAM83G LTBP2 MAP3K1 CYFIP2 ADAMTSL2 COL1A1 | 1.29e-04 | 850 | 82 | 12 | GO:0071363 |
| GeneOntologyBiologicalProcess | wound healing | 1.48e-04 | 493 | 82 | 9 | GO:0042060 | |
| GeneOntologyBiologicalProcess | regulation of complement activation | 1.65e-04 | 27 | 82 | 3 | GO:0030449 | |
| GeneOntologyBiologicalProcess | ERBB2 signaling pathway | 1.65e-04 | 27 | 82 | 3 | GO:0038128 | |
| GeneOntologyBiologicalProcess | response to growth factor | COL3A1 CYFIP1 ADAMTS3 EGFR SPRY4 SRC FAM83G LTBP2 MAP3K1 CYFIP2 ADAMTSL2 COL1A1 | 1.84e-04 | 883 | 82 | 12 | GO:0070848 |
| GeneOntologyBiologicalProcess | negative regulation of cell-substrate adhesion | 2.16e-04 | 74 | 82 | 4 | GO:0010812 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 2.25e-04 | 410 | 82 | 8 | GO:0031589 | |
| GeneOntologyBiologicalProcess | activation of membrane attack complex | 2.32e-04 | 6 | 82 | 2 | GO:0001905 | |
| GeneOntologyBiologicalProcess | response to wounding | 2.79e-04 | 659 | 82 | 10 | GO:0009611 | |
| GeneOntologyBiologicalProcess | post-translational protein modification | TRIM43B USP13 TRIM75 RNF185 TRAIP ANKIB1 BAZ1B FBXL17 TRIM43 KLHL18 ESCO1 MAP3K1 HERC5 | 3.02e-04 | 1074 | 82 | 13 | GO:0043687 |
| GeneOntologyBiologicalProcess | neurotrophin TRK receptor signaling pathway | 3.32e-04 | 34 | 82 | 3 | GO:0048011 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | 3.62e-04 | 333 | 82 | 7 | GO:0051056 | |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | 3.68e-04 | 334 | 82 | 7 | GO:0060249 | |
| GeneOntologyBiologicalProcess | tissue homeostasis | 3.68e-04 | 334 | 82 | 7 | GO:0001894 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | COL3A1 ADAMTS19 COL5A2 CYFIP1 ADAMTS3 SRC FHOD3 LTBP2 DNAI3 MAP3K1 CYFIP2 COL1A1 | 3.85e-04 | 957 | 82 | 12 | GO:0097435 |
| GeneOntologyBiologicalProcess | positive regulation of Wnt signaling pathway | 4.20e-04 | 158 | 82 | 5 | GO:0030177 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation, classical pathway | 4.30e-04 | 8 | 82 | 2 | GO:0045959 | |
| GeneOntologyBiologicalProcess | positive regulation of neurotrophin TRK receptor signaling pathway | 4.30e-04 | 8 | 82 | 2 | GO:0051388 | |
| GeneOntologyBiologicalProcess | positive regulation of small GTPase mediated signal transduction | 4.97e-04 | 92 | 82 | 4 | GO:0051057 | |
| GeneOntologyBiologicalProcess | positive regulation of complement activation | 5.52e-04 | 9 | 82 | 2 | GO:0045917 | |
| GeneOntologyBiologicalProcess | positive regulation of Rho protein signal transduction | 5.79e-04 | 41 | 82 | 3 | GO:0035025 | |
| GeneOntologyBiologicalProcess | aorta morphogenesis | 5.79e-04 | 41 | 82 | 3 | GO:0035909 | |
| GeneOntologyBiologicalProcess | post-embryonic animal morphogenesis | 6.88e-04 | 10 | 82 | 2 | GO:0009886 | |
| GeneOntologyBiologicalProcess | regulation of complement activation, classical pathway | 6.88e-04 | 10 | 82 | 2 | GO:0030450 | |
| GeneOntologyBiologicalProcess | cytolysis by host of symbiont cells | 6.88e-04 | 10 | 82 | 2 | GO:0051838 | |
| GeneOntologyBiologicalProcess | complement activation, classical pathway | 7.13e-04 | 44 | 82 | 3 | GO:0006958 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | EPHB4 CYFIP1 ADAMTS3 EGFR SIPA1L1 SPRY4 SRC CYFIP2 PTK6 COL1A1 | 7.43e-04 | 747 | 82 | 10 | GO:0007169 |
| GeneOntologyBiologicalProcess | neurotrophin signaling pathway | 8.66e-04 | 47 | 82 | 3 | GO:0038179 | |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response mediated by circulating immunoglobulin | 1.00e-03 | 12 | 82 | 2 | GO:0002924 | |
| GeneOntologyCellularComponent | extracellular matrix | COL3A1 CCN4 ADAMTS19 COL5A2 LAMB4 ADAMTSL1 VWF HMCN1 ADAMTS3 ADAMTS9 WNT6 LTBP2 ADAMTS13 PLG ADAMTSL3 MUC2 SSPOP ADAMTSL2 COL1A1 | 5.19e-12 | 656 | 81 | 19 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL3A1 CCN4 ADAMTS19 COL5A2 LAMB4 ADAMTSL1 VWF HMCN1 ADAMTS3 ADAMTS9 WNT6 LTBP2 ADAMTS13 PLG ADAMTSL3 MUC2 SSPOP ADAMTSL2 COL1A1 | 5.47e-12 | 658 | 81 | 19 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL3A1 COL5A2 LAMB4 ADAMTSL1 VWF HMCN1 ADAMTS3 ADAMTS9 LTBP2 PLG MUC2 SSPOP COL1A1 | 1.20e-07 | 530 | 81 | 13 | GO:0062023 |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 1.20e-05 | 12 | 81 | 3 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 1.20e-05 | 12 | 81 | 3 | GO:0098643 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 7.09e-05 | 21 | 81 | 3 | GO:0098644 | |
| GeneOntologyCellularComponent | ruffle | 1.49e-04 | 206 | 81 | 6 | GO:0001726 | |
| GeneOntologyCellularComponent | cell surface | TNFRSF9 VWF EGFR ADAMTS9 WNT6 RTN4R CD38 CLEC4G ADAMTS13 LY6K PLG CR1 CR1L | 3.25e-04 | 1111 | 81 | 13 | GO:0009986 |
| GeneOntologyCellularComponent | cell leading edge | 7.06e-04 | 500 | 81 | 8 | GO:0031252 | |
| GeneOntologyCellularComponent | SCAR complex | 9.54e-04 | 12 | 81 | 2 | GO:0031209 | |
| GeneOntologyCellularComponent | dendritic growth cone | 9.54e-04 | 12 | 81 | 2 | GO:0044294 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 1.83e-03 | 332 | 81 | 6 | GO:0005788 | |
| GeneOntologyCellularComponent | side of membrane | 2.00e-03 | 875 | 81 | 10 | GO:0098552 | |
| GeneOntologyCellularComponent | dendrite terminus | 2.69e-03 | 20 | 81 | 2 | GO:0044292 | |
| GeneOntologyCellularComponent | membrane raft | 2.82e-03 | 362 | 81 | 6 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 2.90e-03 | 364 | 81 | 6 | GO:0098857 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 3.99e-03 | 519 | 81 | 7 | GO:0009897 | |
| HumanPheno | Arteriovenous fistula | 6.97e-07 | 12 | 33 | 4 | HP:0004947 | |
| HumanPheno | Cervical insufficiency | 9.87e-07 | 4 | 33 | 3 | HP:0030009 | |
| HumanPheno | Abnormal uterine cervix morphology | 1.00e-06 | 13 | 33 | 4 | HP:0012888 | |
| HumanPheno | Arteriovenous malformation | 4.30e-06 | 108 | 33 | 7 | HP:0100026 | |
| HumanPheno | Molluscoid pseudotumors | 8.52e-06 | 7 | 33 | 3 | HP:0000993 | |
| HumanPheno | Uterine prolapse | 8.52e-06 | 7 | 33 | 3 | HP:0000139 | |
| HumanPheno | Genital hernia | 1.36e-05 | 8 | 33 | 3 | HP:0100823 | |
| HumanPheno | Arterial rupture | 1.36e-05 | 8 | 33 | 3 | HP:0025019 | |
| HumanPheno | Cigarette-paper scars | 2.88e-05 | 10 | 33 | 3 | HP:0001073 | |
| HumanPheno | Arterial dissection | 5.24e-05 | 12 | 33 | 3 | HP:0005294 | |
| HumanPheno | Bladder diverticulum | 7.43e-05 | 36 | 33 | 4 | HP:0000015 | |
| HumanPheno | Subcutaneous spheroids | 1.22e-04 | 3 | 33 | 2 | HP:0025014 | |
| HumanPheno | Premature rupture of membranes | 1.58e-04 | 17 | 33 | 3 | HP:0001788 | |
| HumanPheno | Abnormal mitral valve morphology | 1.74e-04 | 257 | 33 | 8 | HP:0001633 | |
| HumanPheno | Piezogenic pedal papules | 2.42e-04 | 4 | 33 | 2 | HP:0025509 | |
| HumanPheno | Incisional hernia | 2.42e-04 | 4 | 33 | 2 | HP:0004872 | |
| HumanPheno | Abnormal atrioventricular valve morphology | COL3A1 ADAMTS19 COL5A2 VWF BAZ1B FHOD3 LTBP2 ADAMTSL2 COL1A1 | 2.71e-04 | 350 | 33 | 9 | HP:0006705 |
| HumanPheno | Prolonged bleeding time | 2.73e-04 | 50 | 33 | 4 | HP:0003010 | |
| HumanPheno | Subcutaneous nodule | 3.19e-04 | 95 | 33 | 5 | HP:0001482 | |
| HumanPheno | Abnormal atrioventricular valve physiology | 3.62e-04 | 215 | 33 | 7 | HP:0031650 | |
| HumanPheno | Abnormality of the female genitalia | COL3A1 COL5A2 KLLN VWF TRAIP SPRY4 SRC BAZ1B EWSR1 GNAS PLG MAP3K1 COL1A1 | 4.01e-04 | 741 | 33 | 13 | HP:0010460 |
| HumanPheno | Laryngeal edema | 4.02e-04 | 5 | 33 | 2 | HP:0012027 | |
| HumanPheno | Scarring | 4.43e-04 | 102 | 33 | 5 | HP:0100699 | |
| MousePheno | abnormal maternal decidual layer morphology | 4.41e-06 | 25 | 63 | 4 | MP:0004256 | |
| Domain | TSP_1 | CCN4 ADAMTS19 ADAMTSL1 HMCN1 ADAMTS3 ADAMTS9 ADAMTS13 C6 ADAMTSL3 SSPOP ADAMTSL2 | 1.94e-15 | 63 | 79 | 11 | PF00090 |
| Domain | TSP1 | CCN4 ADAMTS19 ADAMTSL1 HMCN1 ADAMTS3 ADAMTS9 ADAMTS13 C6 ADAMTSL3 SSPOP ADAMTSL2 | 2.80e-15 | 65 | 79 | 11 | SM00209 |
| Domain | TSP1_rpt | CCN4 ADAMTS19 ADAMTSL1 HMCN1 ADAMTS3 ADAMTS9 ADAMTS13 C6 ADAMTSL3 SSPOP ADAMTSL2 | 2.80e-15 | 65 | 79 | 11 | IPR000884 |
| Domain | TSP1 | CCN4 ADAMTS19 ADAMTSL1 HMCN1 ADAMTS3 ADAMTS9 ADAMTS13 C6 ADAMTSL3 SSPOP ADAMTSL2 | 2.80e-15 | 65 | 79 | 11 | PS50092 |
| Domain | Peptidase_M12B_ADAM-TS | ADAMTS19 ADAMTSL1 ADAMTS3 ADAMTS9 ADAMTS13 ADAMTSL3 ADAMTSL2 | 6.03e-12 | 24 | 79 | 7 | IPR013273 |
| Domain | VWFC_1 | 1.40e-10 | 36 | 79 | 7 | PS01208 | |
| Domain | VWC | 2.10e-10 | 38 | 79 | 7 | SM00214 | |
| Domain | VWFC_2 | 2.10e-10 | 38 | 79 | 7 | PS50184 | |
| Domain | VWF_dom | 4.42e-10 | 42 | 79 | 7 | IPR001007 | |
| Domain | PLAC | 1.32e-08 | 19 | 79 | 5 | PS50900 | |
| Domain | PLAC | 1.32e-08 | 19 | 79 | 5 | IPR010909 | |
| Domain | VWC | 1.08e-07 | 28 | 79 | 5 | PF00093 | |
| Domain | PLAC | 2.87e-07 | 14 | 79 | 4 | PF08686 | |
| Domain | CTCK_1 | 8.67e-07 | 18 | 79 | 4 | PS01185 | |
| Domain | ADAM_spacer1 | 2.47e-06 | 23 | 79 | 4 | IPR010294 | |
| Domain | ADAM_spacer1 | 2.47e-06 | 23 | 79 | 4 | PF05986 | |
| Domain | Sushi | 2.65e-06 | 52 | 79 | 5 | PF00084 | |
| Domain | CCP | 3.20e-06 | 54 | 79 | 5 | SM00032 | |
| Domain | Cys_knot_C | 3.51e-06 | 25 | 79 | 4 | IPR006207 | |
| Domain | CTCK_2 | 3.51e-06 | 25 | 79 | 4 | PS01225 | |
| Domain | SUSHI | 3.84e-06 | 56 | 79 | 5 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 4.20e-06 | 57 | 79 | 5 | IPR000436 | |
| Domain | Growth_fac_rcpt_ | 4.34e-06 | 156 | 79 | 7 | IPR009030 | |
| Domain | Fib_collagen_C | 1.17e-05 | 11 | 79 | 3 | IPR000885 | |
| Domain | COLFI | 1.17e-05 | 11 | 79 | 3 | PF01410 | |
| Domain | NC1_FIB | 1.17e-05 | 11 | 79 | 3 | PS51461 | |
| Domain | Fib_collagen_C | 1.17e-05 | 11 | 79 | 3 | PD002078 | |
| Domain | COLFI | 1.17e-05 | 11 | 79 | 3 | SM00038 | |
| Domain | TIL | 1.56e-05 | 12 | 79 | 3 | PF01826 | |
| Domain | C8 | 1.56e-05 | 12 | 79 | 3 | PF08742 | |
| Domain | Cytoplasmic_FMR1-int | 1.77e-05 | 2 | 79 | 2 | IPR008081 | |
| Domain | FragX_IP | 1.77e-05 | 2 | 79 | 2 | PF05994 | |
| Domain | Unchr_dom_Cys-rich | 2.02e-05 | 13 | 79 | 3 | IPR014853 | |
| Domain | C8 | 2.02e-05 | 13 | 79 | 3 | SM00832 | |
| Domain | DISINTEGRIN_1 | 2.41e-05 | 40 | 79 | 4 | PS00427 | |
| Domain | Reprolysin | 2.41e-05 | 40 | 79 | 4 | PF01421 | |
| Domain | ADAM_MEPRO | 2.41e-05 | 40 | 79 | 4 | PS50215 | |
| Domain | DISINTEGRIN_2 | 2.41e-05 | 40 | 79 | 4 | PS50214 | |
| Domain | Peptidase_M12B | 2.41e-05 | 40 | 79 | 4 | IPR001590 | |
| Domain | TIL_dom | 2.56e-05 | 14 | 79 | 3 | IPR002919 | |
| Domain | Disintegrin_dom | 2.67e-05 | 41 | 79 | 4 | IPR001762 | |
| Domain | VWD | 3.92e-05 | 16 | 79 | 3 | SM00216 | |
| Domain | VWF_type-D | 3.92e-05 | 16 | 79 | 3 | IPR001846 | |
| Domain | VWFD | 3.92e-05 | 16 | 79 | 3 | PS51233 | |
| Domain | VWD | 3.92e-05 | 16 | 79 | 3 | PF00094 | |
| Domain | VWC_out | 6.72e-05 | 19 | 79 | 3 | SM00215 | |
| Domain | Znf_RING | 7.03e-05 | 326 | 79 | 8 | IPR001841 | |
| Domain | DUF1394 | 1.05e-04 | 4 | 79 | 2 | PF07159 | |
| Domain | DUF1394 | 1.05e-04 | 4 | 79 | 2 | IPR009828 | |
| Domain | CT | 1.06e-04 | 22 | 79 | 3 | SM00041 | |
| Domain | - | 1.15e-04 | 449 | 79 | 9 | 3.30.40.10 | |
| Domain | EGF_2 | 1.30e-04 | 265 | 79 | 7 | PS01186 | |
| Domain | Znf_RING/FYVE/PHD | 1.36e-04 | 459 | 79 | 9 | IPR013083 | |
| Domain | Pkinase_Tyr | 2.18e-04 | 129 | 79 | 5 | PF07714 | |
| Domain | ZF_RING_1 | 2.31e-04 | 291 | 79 | 7 | PS00518 | |
| Domain | ZF_RING_2 | 2.67e-04 | 298 | 79 | 7 | PS50089 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 2.98e-04 | 138 | 79 | 5 | IPR001245 | |
| Domain | RING | 3.07e-04 | 305 | 79 | 7 | SM00184 | |
| Domain | MetalloPept_cat_dom | 3.85e-04 | 81 | 79 | 4 | IPR024079 | |
| Domain | - | 3.85e-04 | 81 | 79 | 4 | 3.40.390.10 | |
| Domain | TyrKc | 5.28e-04 | 88 | 79 | 4 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 5.28e-04 | 88 | 79 | 4 | IPR020635 | |
| Domain | Peptidase_M12B_N | 5.96e-04 | 39 | 79 | 3 | IPR002870 | |
| Domain | Pep_M12B_propep | 5.96e-04 | 39 | 79 | 3 | PF01562 | |
| Domain | EGF_1 | 7.38e-04 | 255 | 79 | 6 | PS00022 | |
| Domain | PROTEIN_KINASE_TYR | 7.62e-04 | 97 | 79 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 7.62e-04 | 97 | 79 | 4 | IPR008266 | |
| Domain | - | 7.78e-04 | 10 | 79 | 2 | 4.10.1060.10 | |
| Domain | ZINC_PROTEASE | 7.92e-04 | 98 | 79 | 4 | PS00142 | |
| Domain | Pept_M10_metallopeptidase | 7.96e-04 | 43 | 79 | 3 | IPR001818 | |
| Domain | EGF-like_CS | 8.33e-04 | 261 | 79 | 6 | IPR013032 | |
| Domain | Zinc_finger_PHD-type_CS | 2.63e-03 | 65 | 79 | 3 | IPR019786 | |
| Domain | EGF_3 | 3.20e-03 | 235 | 79 | 5 | PS50026 | |
| Domain | zf-RanBP | 3.86e-03 | 22 | 79 | 2 | PF00641 | |
| Domain | ZnF_RBZ | 4.22e-03 | 23 | 79 | 2 | SM00547 | |
| Domain | ZF_RANBP2_2 | 4.22e-03 | 23 | 79 | 2 | PS50199 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | ADAMTS19 ADAMTSL1 ADAMTS3 ADAMTS9 ADAMTS13 ADAMTSL3 SSPOP ADAMTSL2 | 6.32e-12 | 39 | 64 | 8 | M27417 |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | ADAMTS19 ADAMTSL1 ADAMTS3 ADAMTS9 ADAMTS13 ADAMTSL3 SSPOP ADAMTSL2 | 6.32e-12 | 39 | 64 | 8 | MM15165 |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | ADAMTS19 ADAMTSL1 ADAMTS3 ADAMTS9 ADAMTS13 ADAMTSL3 SSPOP ADAMTSL2 | 6.85e-10 | 68 | 64 | 8 | M27303 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | ADAMTS19 ADAMTSL1 ADAMTS3 ADAMTS9 ADAMTS13 ADAMTSL3 MUC2 SSPOP ADAMTSL2 | 1.37e-09 | 109 | 64 | 9 | MM15164 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | ADAMTS19 ADAMTSL1 ADAMTS3 ADAMTS9 ADAMTS13 ADAMTSL3 SSPOP ADAMTSL2 | 3.51e-08 | 111 | 64 | 8 | M27416 |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | ADAMTS19 ADAMTSL1 ADAMTS3 ADAMTS9 ADAMTS13 ADAMTSL3 SSPOP ADAMTSL2 | 2.52e-07 | 143 | 64 | 8 | M27275 |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.42e-06 | 19 | 64 | 4 | MM15512 | |
| Pathway | REACTOME_DEFECTS_OF_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 4.92e-06 | 8 | 64 | 3 | M48236 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 7.83e-06 | 300 | 64 | 9 | M610 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 9.69e-06 | 30 | 64 | 4 | M27772 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 9.69e-06 | 30 | 64 | 4 | MM15517 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | ADAMTS19 ADAMTSL1 ADAMTS3 ADAMTS9 ADAMTS13 ADAMTSL3 SSPOP ADAMTSL2 | 1.64e-05 | 250 | 64 | 8 | M27554 |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 1.91e-05 | 12 | 64 | 3 | MM15093 | |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 1.91e-05 | 12 | 64 | 3 | M27352 | |
| Pathway | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 1.91e-05 | 12 | 64 | 3 | MM15452 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.06e-05 | 258 | 64 | 8 | MM14572 | |
| Pathway | WP_FOCAL_ADHESION | 2.12e-05 | 187 | 64 | 7 | MM15913 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.37e-05 | 76 | 64 | 5 | MM14867 | |
| Pathway | KEGG_FOCAL_ADHESION | 3.16e-05 | 199 | 64 | 7 | M7253 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 3.45e-05 | 41 | 64 | 4 | M27778 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 3.85e-05 | 84 | 64 | 5 | M7098 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 4.08e-05 | 85 | 64 | 5 | M16441 | |
| Pathway | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 4.79e-05 | 16 | 64 | 3 | M9450 | |
| Pathway | REACTOME_DISEASES_OF_HEMOSTASIS | 8.21e-05 | 19 | 64 | 3 | M48230 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.06e-04 | 418 | 64 | 9 | MM15587 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.27e-04 | 57 | 64 | 4 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.36e-04 | 58 | 64 | 4 | M2049 | |
| Pathway | WP_COMPLEMENT_AND_COAGULATION_CASCADES | 1.36e-04 | 58 | 64 | 4 | M39649 | |
| Pathway | WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES | 1.46e-04 | 59 | 64 | 4 | M48343 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.66e-04 | 61 | 64 | 4 | MM14637 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 2.39e-04 | 67 | 64 | 4 | MM15345 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 2.39e-04 | 67 | 64 | 4 | M26999 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 2.42e-04 | 27 | 64 | 3 | M27217 | |
| Pathway | KEGG_COMPLEMENT_AND_COAGULATION_CASCADES | 2.68e-04 | 69 | 64 | 4 | M16894 | |
| Pathway | WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING | 2.70e-04 | 28 | 64 | 3 | M39572 | |
| Pathway | WP_FOCAL_ADHESION | 2.79e-04 | 199 | 64 | 6 | M39402 | |
| Pathway | REACTOME_PTK6_PROMOTES_HIF1A_STABILIZATION | 3.01e-04 | 6 | 64 | 2 | M27754 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_CFHR | 3.01e-04 | 6 | 64 | 2 | M47880 | |
| Pathway | REACTOME_PTK6_PROMOTES_HIF1A_STABILIZATION | 3.01e-04 | 6 | 64 | 2 | MM15500 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 3.50e-04 | 74 | 64 | 4 | M160 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 3.88e-04 | 76 | 64 | 4 | MM14573 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 4.03e-04 | 32 | 64 | 3 | MM14924 | |
| Pathway | REACTOME_ENHANCED_BINDING_OF_GP1BA_VARIANT_TO_VWF_MULTIMER_COLLAGEN | 4.20e-04 | 7 | 64 | 2 | M48265 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 4.28e-04 | 140 | 64 | 5 | M587 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 4.50e-04 | 79 | 64 | 4 | M27643 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 6.28e-04 | 532 | 64 | 9 | M27870 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 6.72e-04 | 38 | 64 | 3 | MM15456 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 7.26e-04 | 39 | 64 | 3 | M10735 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 7.37e-04 | 90 | 64 | 4 | M631 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 8.41e-04 | 41 | 64 | 3 | MM15538 | |
| Pathway | PID_UPA_UPAR_PATHWAY | 9.03e-04 | 42 | 64 | 3 | M174 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 9.39e-04 | 96 | 64 | 4 | M39581 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.03e-03 | 44 | 64 | 3 | M27812 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 1.03e-03 | 44 | 64 | 3 | MM14520 | |
| Pathway | BIOCARTA_EGFR_SMRTE_PATHWAY | 1.09e-03 | 11 | 64 | 2 | M18837 | |
| Pathway | BIOCARTA_EGFR_SMRTE_PATHWAY | 1.09e-03 | 11 | 64 | 2 | MM1432 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 1.09e-03 | 11 | 64 | 2 | MM15478 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 1.13e-03 | 101 | 64 | 4 | M1979 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.18e-03 | 46 | 64 | 3 | M198 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.25e-03 | 47 | 64 | 3 | MM14925 | |
| Pathway | PID_ERBB1_DOWNSTREAM_PATHWAY | 1.31e-03 | 105 | 64 | 4 | M164 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 1.50e-03 | 50 | 64 | 3 | M553 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.50e-03 | 50 | 64 | 3 | MM14796 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 1.53e-03 | 13 | 64 | 2 | M27729 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY | 1.53e-03 | 13 | 64 | 2 | M47594 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.77e-03 | 114 | 64 | 4 | MM14571 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.78e-03 | 53 | 64 | 3 | MM14566 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 1.83e-03 | 115 | 64 | 4 | M19752 | |
| Pathway | WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER | 1.88e-03 | 54 | 64 | 3 | M42568 | |
| Pathway | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 2.05e-03 | 15 | 64 | 2 | M12101 | |
| Pathway | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 2.05e-03 | 15 | 64 | 2 | M1262 | |
| Pathway | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 2.05e-03 | 15 | 64 | 2 | MM14959 | |
| Pathway | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 2.05e-03 | 15 | 64 | 2 | MM14961 | |
| Pathway | BIOCARTA_SPRY_PATHWAY | 2.34e-03 | 16 | 64 | 2 | MM1500 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.42e-03 | 59 | 64 | 3 | M27218 | |
| Pathway | BIOCARTA_SPRY_PATHWAY | 2.64e-03 | 17 | 64 | 2 | M1389 | |
| Pathway | PID_SYNDECAN_3_PATHWAY | 2.64e-03 | 17 | 64 | 2 | M251 | |
| Pathway | REACTOME_GAB1_SIGNALOSOME | 2.64e-03 | 17 | 64 | 2 | MM14700 | |
| Pathway | PID_NFKAPPAB_ATYPICAL_PATHWAY | 2.64e-03 | 17 | 64 | 2 | M26 | |
| Pathway | REACTOME_GAB1_SIGNALOSOME | 2.64e-03 | 17 | 64 | 2 | M10450 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.66e-03 | 61 | 64 | 3 | M27103 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 2.92e-03 | 63 | 64 | 3 | M11187 | |
| Pathway | BIOCARTA_41BB_PATHWAY | 2.96e-03 | 18 | 64 | 2 | M2064 | |
| Pathway | REACTOME_EPHRIN_SIGNALING | 2.96e-03 | 18 | 64 | 2 | MM15024 | |
| Pathway | BIOCARTA_41BB_PATHWAY | 2.96e-03 | 18 | 64 | 2 | MM1511 | |
| Pathway | WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS | 2.96e-03 | 18 | 64 | 2 | M39421 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 3.05e-03 | 64 | 64 | 3 | M26953 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 3.28e-03 | 135 | 64 | 4 | MM14781 | |
| Pathway | REACTOME_EPHRIN_SIGNALING | 3.30e-03 | 19 | 64 | 2 | M27310 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 3.30e-03 | 19 | 64 | 2 | M27221 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 3.33e-03 | 66 | 64 | 3 | M18 | |
| Pathway | WP_BMP_SIGNALING_PATHWAY_IN_EYELID_DEVELOPMENT | 3.66e-03 | 20 | 64 | 2 | MM15907 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 3.66e-03 | 20 | 64 | 2 | MM15061 | |
| Pathway | WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT | 3.66e-03 | 20 | 64 | 2 | M39624 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPE_TO_RAC_SIGNALING_PATHWAY | 3.66e-03 | 20 | 64 | 2 | M47737 | |
| Pathway | WP_UROTENSINIIMEDIATED_SIGNALING | 3.78e-03 | 69 | 64 | 3 | M48052 | |
| Pathway | PID_ECADHERIN_KERATINOCYTE_PATHWAY | 4.03e-03 | 21 | 64 | 2 | M184 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_ACTIN_SIGNALING_PATHWAY | 4.03e-03 | 21 | 64 | 2 | M47722 | |
| Pathway | REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING | 4.09e-03 | 71 | 64 | 3 | MM15590 | |
| Pathway | WP_BLOOD_CLOTTING_CASCADE | 4.42e-03 | 22 | 64 | 2 | M39480 | |
| Pubmed | CCN4 ADAMTS19 ADAMTSL1 HMCN1 ADAMTS3 ADAMTS9 ADAMTS13 C6 ADAMTSL3 SSPOP ADAMTSL2 | 3.11e-17 | 75 | 83 | 11 | 20637190 | |
| Pubmed | 2.65e-10 | 167 | 83 | 9 | 22159717 | ||
| Pubmed | 4.01e-10 | 175 | 83 | 9 | 28071719 | ||
| Pubmed | 1.03e-08 | 64 | 83 | 6 | 22261194 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 24449821 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 14667842 | ||
| Pubmed | 3.70e-08 | 39 | 83 | 5 | 30566624 | ||
| Pubmed | ADAMTS-3, -13, -16, and -19 levels in patients with habitual abortion. | 5.23e-08 | 4 | 83 | 3 | 28088271 | |
| Pubmed | 2.61e-07 | 6 | 83 | 3 | 20063990 | ||
| Pubmed | 2.61e-07 | 6 | 83 | 3 | 16556917 | ||
| Pubmed | 7.28e-07 | 8 | 83 | 3 | 18816857 | ||
| Pubmed | Fgf10 deficiency is causative for lethality in a mouse model of bronchopulmonary dysplasia. | 1.03e-06 | 32 | 83 | 4 | 27770432 | |
| Pubmed | 1.09e-06 | 9 | 83 | 3 | 18947875 | ||
| Pubmed | Loss of ADAMTS19 causes progressive non-syndromic heart valve disease. | 1.09e-06 | 9 | 83 | 3 | 31844321 | |
| Pubmed | 1.55e-06 | 10 | 83 | 3 | 18273061 | ||
| Pubmed | 1.55e-06 | 10 | 83 | 3 | 30738849 | ||
| Pubmed | 1.55e-06 | 10 | 83 | 3 | 14559231 | ||
| Pubmed | 1.55e-06 | 10 | 83 | 3 | 11167130 | ||
| Pubmed | 1.88e-06 | 153 | 83 | 6 | 25037231 | ||
| Pubmed | 2.13e-06 | 11 | 83 | 3 | 2745554 | ||
| Pubmed | 5.49e-06 | 105 | 83 | 5 | 9628581 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 28102428 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 17296575 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 32065383 | ||
| Pubmed | Functional identification of transcription control sequences of the mouse Crry gene. | 5.63e-06 | 2 | 83 | 2 | 8335915 | |
| Pubmed | ADAMTS13 deficiency exacerbates VWF-dependent acute myocardial ischemia/reperfusion injury in mice. | 5.63e-06 | 2 | 83 | 2 | 22983446 | |
| Pubmed | N-Glycans of ADAMTS13 modulate its secretion and von Willebrand factor cleaving activity. | 5.63e-06 | 2 | 83 | 2 | 18981290 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 15975930 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 18594011 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 27636223 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 21779388 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 25201004 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 25010251 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 16420575 | ||
| Pubmed | Von Willebrand factor and ADAMTS13: a candidate couple for preeclampsia pathophysiology. | 5.63e-06 | 2 | 83 | 2 | 21512165 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 26168189 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 19765212 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 11983694 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 24740645 | ||
| Pubmed | Crry/p65, a membrane complement regulatory protein, has costimulatory properties on mouse T cells. | 5.63e-06 | 2 | 83 | 2 | 10779754 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 27444201 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 24106205 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 16444293 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 19190805 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 19190814 | ||
| Pubmed | Different dysregulations of CYFIP1 and CYFIP2 in distinct types of dementia. | 5.63e-06 | 2 | 83 | 2 | 38128786 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 34260947 | ||
| Pubmed | ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men. | 5.63e-06 | 2 | 83 | 2 | 17053057 | |
| Pubmed | Characterization of ADAMTS13 and von Willebrand factor levels in septic and non-septic ICU patients. | 5.63e-06 | 2 | 83 | 2 | 33606732 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 20200350 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 16912226 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 19812385 | ||
| Pubmed | Differential expression of procollagen genes between mid- and late-gestational fetal fibroblasts. | 5.63e-06 | 2 | 83 | 2 | 19560165 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 29729651 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 1730912 | ||
| Pubmed | Collagen synthesis is not altered in women with stress urinary incontinence. | 5.63e-06 | 2 | 83 | 2 | 15227656 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 16141351 | ||
| Pubmed | Domain-specific mechanical modulation of VWF-ADAMTS13 interaction. | 5.63e-06 | 2 | 83 | 2 | 31067148 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 21705658 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 33343584 | ||
| Pubmed | Zinc and calcium ions cooperatively modulate ADAMTS13 activity. | 5.63e-06 | 2 | 83 | 2 | 16286459 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 30936056 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 25977583 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 23040566 | ||
| Pubmed | Impact of mutations in the von Willebrand factor A2 domain on ADAMTS13-dependent proteolysis. | 5.63e-06 | 2 | 83 | 2 | 16322474 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 19740350 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 20032502 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 19305428 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 25846964 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 29887594 | ||
| Pubmed | Force-induced cleavage of single VWFA1A2A3 tridomains by ADAMTS-13. | 5.63e-06 | 2 | 83 | 2 | 19897584 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 11185568 | ||
| Pubmed | Impact of the von Willebrand factor-ADAMTS-13 axis on the risk of future venous thromboembolism. | 5.63e-06 | 2 | 83 | 2 | 36736832 | |
| Pubmed | Human alpha 1(III) and alpha 2(V) procollagen genes are located on the long arm of chromosome 2. | 5.63e-06 | 2 | 83 | 2 | 3858826 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 32441353 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 25904363 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 12775718 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 33369998 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 23377784 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 24351199 | ||
| Pubmed | Disulfide bond reduction of von Willebrand factor by ADAMTS-13. | 5.63e-06 | 2 | 83 | 2 | 20946172 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 25432063 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 7704020 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 17804738 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 27889474 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 16203734 | ||
| Pubmed | ADAMTS13 controls vascular remodeling by modifying VWF reactivity during stroke recovery. | 5.63e-06 | 2 | 83 | 2 | 28428179 | |
| Pubmed | Identification of ADAMTS13 peptide sequences binding to von Willebrand factor. | 5.63e-06 | 2 | 83 | 2 | 19944670 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 18983500 | ||
| Pubmed | Unconjugated bilirubin inhibits proteolytic cleavage of von Willebrand factor by ADAMTS13 protease. | 5.63e-06 | 2 | 83 | 2 | 25782102 | |
| Pubmed | Von Willebrand Factor Adhesive Activity and ADAMTS13 Protease Activity in HIV-1-Infected Men. | 5.63e-06 | 2 | 83 | 2 | 30745808 | |
| Pubmed | TAE226-induced apoptosis in breast cancer cells with overexpressed Src or EGFR. | 5.63e-06 | 2 | 83 | 2 | 17849451 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 28087247 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 33404693 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 38097740 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 27363273 | ||
| Pubmed | A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF. | 5.63e-06 | 2 | 83 | 2 | 19587373 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 16899464 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 30929293 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 25916953 | ||
| Interaction | MATK interactions | 8.40e-07 | 43 | 82 | 5 | int:MATK | |
| Interaction | VWF interactions | 8.39e-06 | 32 | 82 | 4 | int:VWF | |
| Interaction | COL1A2 interactions | 1.65e-05 | 78 | 82 | 5 | int:COL1A2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q31 | 3.50e-04 | 75 | 83 | 3 | chr1q31 | |
| Cytoband | 1q31.3 | 3.81e-04 | 16 | 83 | 2 | 1q31.3 | |
| Cytoband | 20q13.3 | 6.01e-04 | 20 | 83 | 2 | 20q13.3 | |
| Cytoband | 1p22.3 | 7.29e-04 | 22 | 83 | 2 | 1p22.3 | |
| Cytoband | 2q11.1 | 1.18e-03 | 28 | 83 | 2 | 2q11.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p22 | 4.19e-03 | 53 | 83 | 2 | chr9p22 | |
| Cytoband | 22q12.2 | 5.00e-03 | 58 | 83 | 2 | 22q12.2 | |
| GeneFamily | Complement system|Sushi domain containing | 1.29e-07 | 36 | 61 | 5 | 492 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 4.38e-07 | 19 | 61 | 4 | 50 | |
| GeneFamily | ADAMTS like | 1.27e-06 | 7 | 61 | 3 | 947 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.35e-06 | 57 | 61 | 5 | 1179 | |
| GeneFamily | Collagens | 5.00e-04 | 46 | 61 | 3 | 490 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 2.26e-03 | 21 | 61 | 2 | 89 | |
| GeneFamily | Ring finger proteins | 2.33e-03 | 275 | 61 | 5 | 58 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 4.06e-03 | 95 | 61 | 3 | 59 | |
| Coexpression | NABA_MATRISOME | COL3A1 CCN4 ADAMTS19 COL5A2 LAMB4 ADAMTSL1 VWF HMCN1 ADAMTS3 ADAMTS9 WNT6 CLEC4G LTBP2 ADAMTS13 PLG ADAMTSL3 MUC2 SSPOP ADAMTSL2 COL1A1 | 3.69e-11 | 1026 | 82 | 20 | M5889 |
| Coexpression | NABA_MATRISOME | COL3A1 CCN4 ADAMTS19 COL5A2 ADAMTSL1 VWF HMCN1 ADAMTS3 ADAMTS9 WNT6 CLEC4G LTBP2 ADAMTS13 PLG ADAMTSL3 MUC2 SSPOP ADAMTSL2 COL1A1 | 2.19e-10 | 1008 | 82 | 19 | MM17056 |
| Coexpression | NABA_CORE_MATRISOME | 2.03e-07 | 275 | 82 | 9 | M5884 | |
| Coexpression | NABA_ECM_REGULATORS | ADAMTS19 ADAMTSL1 ADAMTS3 ADAMTS9 ADAMTS13 PLG ADAMTSL3 ADAMTSL2 | 8.21e-07 | 238 | 82 | 8 | M3468 |
| Coexpression | NABA_ECM_REGULATORS | ADAMTS19 ADAMTSL1 ADAMTS3 ADAMTS9 ADAMTS13 PLG ADAMTSL3 ADAMTSL2 | 9.31e-07 | 242 | 82 | 8 | MM17062 |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 1.99e-06 | 29 | 82 | 4 | MM17055 | |
| Coexpression | NABA_CORE_MATRISOME | 2.11e-06 | 270 | 82 | 8 | MM17057 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_UP | 1.10e-05 | 44 | 82 | 4 | M18274 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS19 ADAMTSL1 ADAMTS3 ADAMTS9 WNT6 CLEC4G ADAMTS13 PLG ADAMTSL3 MUC2 ADAMTSL2 | 1.86e-05 | 738 | 82 | 11 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS19 ADAMTSL1 ADAMTS3 ADAMTS9 WNT6 CLEC4G ADAMTS13 PLG ADAMTSL3 MUC2 ADAMTSL2 | 2.19e-05 | 751 | 82 | 11 | M5885 |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 2.33e-05 | 18 | 82 | 3 | MM1241 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 2.33e-05 | 18 | 82 | 3 | M13796 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.54e-05 | 196 | 82 | 6 | M3008 | |
| Coexpression | POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN | 4.05e-05 | 61 | 82 | 4 | M8510 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP | 5.33e-05 | 211 | 82 | 6 | M12225 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 6.59e-05 | 69 | 82 | 4 | M10165 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 8.67e-05 | 74 | 82 | 4 | M13547 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 1.23e-04 | 81 | 82 | 4 | M39253 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_STROMAL_CELLS | 1.32e-04 | 156 | 82 | 5 | M40151 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | COL3A1 COL5A2 KRTAP13-4 EGFR ADAMTS9 SPRY4 LTBP2 LY6K ADAMTSL3 COL1A1 | 1.39e-04 | 767 | 82 | 10 | M39209 |
| Coexpression | VERHAAK_GLIOBLASTOMA_CLASSICAL | 1.53e-04 | 161 | 82 | 5 | M2121 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 1.71e-04 | 261 | 82 | 6 | M1834 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 1.80e-04 | 35 | 82 | 3 | MM17054 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 1.80e-04 | 35 | 82 | 3 | M11788 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT | 1.85e-04 | 90 | 82 | 4 | M38984 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 1.96e-04 | 36 | 82 | 3 | MM1212 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 2.06e-04 | 385 | 82 | 7 | M39264 | |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_MELANOMA | 2.30e-04 | 38 | 82 | 3 | M47982 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | COL3A1 COL5A2 ADAMTSL1 HMCN1 FHOD3 LTBP2 ADAMTS13 ADAMTSL2 COL1A1 | 1.28e-10 | 198 | 83 | 9 | bd11b0e9e80449aab979a02c1023e0638c431c7c |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.74e-09 | 191 | 83 | 8 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell|Adult / Lineage, Cell type, age group and donor | 2.80e-08 | 167 | 83 | 7 | d584a8548a5317bd9686b3be8246ae6ed568796b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.02e-08 | 176 | 83 | 7 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.02e-08 | 176 | 83 | 7 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 7.29e-08 | 192 | 83 | 7 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Tumor-Diffuse_large_B-cell_lymphoma-DLBCL-1|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 7.83e-08 | 194 | 83 | 7 | eaeeb84576270cc3fc59002ba33bff9639bb0b02 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.11e-08 | 195 | 83 | 7 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.69e-08 | 197 | 83 | 7 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.99e-08 | 198 | 83 | 7 | 7d2fe57e0f9311ac1e6854402ebc154306eb1ba5 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.63e-08 | 200 | 83 | 7 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.96e-07 | 157 | 83 | 6 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.15e-07 | 158 | 83 | 6 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.64e-07 | 165 | 83 | 6 | 4e13fccd32029e2879e85f8966e582a46c09e4aa | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.12e-07 | 167 | 83 | 6 | fe3338f99f94c0dac37e3d649dfdce82e4a56022 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.90e-07 | 170 | 83 | 6 | 8465c3069bbc08705d070927e712b6bc85ac7c5b | |
| ToppCell | -Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 8.75e-07 | 173 | 83 | 6 | 88be9182fbb1bc83531cd41e59ea57c112a21d54 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.00e-06 | 177 | 83 | 6 | ac90e4ce5be304a5a7473736397327010f2d1999 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.03e-06 | 178 | 83 | 6 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-06 | 178 | 83 | 6 | a493a277d175e5e153410a745b26ebe2e0839ea0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-06 | 178 | 83 | 6 | 371218babddfd3d8a7bb82a46ce65327ee3fcf12 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-06 | 181 | 83 | 6 | 269b39ac65790061d54eab47a8eeb024403f0348 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-06 | 181 | 83 | 6 | cd4f744b6b64ba6c22ec07afd1d3058a2546909d | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-06 | 181 | 83 | 6 | c8395ae872aa80b3ae1ab7c53e57b3ca15aeb0e2 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 1.14e-06 | 181 | 83 | 6 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-06 | 183 | 83 | 6 | ebe369dc80c4fbf8f4dbe947147f8c47507ffb60 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 1.25e-06 | 184 | 83 | 6 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.25e-06 | 184 | 83 | 6 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-06 | 184 | 83 | 6 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-06 | 185 | 83 | 6 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.33e-06 | 186 | 83 | 6 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-06 | 186 | 83 | 6 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.38e-06 | 187 | 83 | 6 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-06 | 187 | 83 | 6 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-06 | 187 | 83 | 6 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-06 | 187 | 83 | 6 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.38e-06 | 187 | 83 | 6 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | -Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.42e-06 | 188 | 83 | 6 | 038f48e8daaeb72716e975d22a6b004a90654960 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 1.42e-06 | 188 | 83 | 6 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | Fibroblast-C|World / shred on cell class and cell subclass (v4) | 1.46e-06 | 189 | 83 | 6 | 58e0400fbab5a0755504275aef5cf7986149abab | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.51e-06 | 190 | 83 | 6 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.51e-06 | 190 | 83 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-06 | 191 | 83 | 6 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.56e-06 | 191 | 83 | 6 | fd8331c7abdd999f55ba43d307945c6abfccbf84 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-06 | 191 | 83 | 6 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.56e-06 | 191 | 83 | 6 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.56e-06 | 191 | 83 | 6 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-06 | 192 | 83 | 6 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-06 | 192 | 83 | 6 | 38d7a24ae205ef91ed2e0f402d8022f2a9cdb243 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-06 | 192 | 83 | 6 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-06 | 192 | 83 | 6 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.60e-06 | 192 | 83 | 6 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-06 | 192 | 83 | 6 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-06 | 192 | 83 | 6 | 04d155897ed075c359933080e36a4ab2150b6e9f | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-06 | 192 | 83 | 6 | 84149a5c6c3b3c9b86aed77cf8e72d99ef099fab | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.60e-06 | 192 | 83 | 6 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-06 | 192 | 83 | 6 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 1.60e-06 | 192 | 83 | 6 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-06 | 193 | 83 | 6 | 316ebdf15f75d88c348f909b643fcd315364ca84 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-06 | 193 | 83 | 6 | 59b8186d0221fba06a16157e9d148399ed801f38 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-06 | 193 | 83 | 6 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-06 | 193 | 83 | 6 | 1afdd3f7d703f4204a2cbfe40e135ac7b09213f7 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.65e-06 | 193 | 83 | 6 | 64edc1d6fb0fe117767d494cf4a5723bf8be2804 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-06 | 193 | 83 | 6 | dc92680b4bb9fc26430c92e03adb839c8c3b3b98 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.65e-06 | 193 | 83 | 6 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.65e-06 | 193 | 83 | 6 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.65e-06 | 193 | 83 | 6 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 1.65e-06 | 193 | 83 | 6 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-06 | 193 | 83 | 6 | 03678162648bd5b1d65a5450b60c8863edbf95c7 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.65e-06 | 193 | 83 | 6 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-06 | 193 | 83 | 6 | 8dc6db335678f3a5cfd36026ad811fed8d9cb4bc | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-06 | 193 | 83 | 6 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related-FDC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.70e-06 | 194 | 83 | 6 | f9fbb043411546d8c9e0321a64165d411f44aeb7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-06 | 194 | 83 | 6 | 8fae8061b350336299aa81f378e07deadbd55123 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 1.70e-06 | 194 | 83 | 6 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-06 | 194 | 83 | 6 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-06 | 194 | 83 | 6 | 29f83cdd63314fff41258937d70b881a5503bfcc | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.70e-06 | 194 | 83 | 6 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-06 | 194 | 83 | 6 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | (5)_Fibroblast-C_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.70e-06 | 194 | 83 | 6 | 29a72e565c19407bbd198cfbc2a78106fe830d05 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-06 | 194 | 83 | 6 | d3db241ea316bbcde6d16618193b474591ad5ce4 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-06 | 194 | 83 | 6 | 4d7d24390fdb379f943ddcc70a63f23955e10163 | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 1.76e-06 | 195 | 83 | 6 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-06 | 195 | 83 | 6 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-06 | 195 | 83 | 6 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.76e-06 | 195 | 83 | 6 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.76e-06 | 195 | 83 | 6 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.76e-06 | 195 | 83 | 6 | 51db90e7611f7d69980878c046505ff34212079b | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 1.81e-06 | 196 | 83 | 6 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | IPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.81e-06 | 196 | 83 | 6 | 7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.81e-06 | 196 | 83 | 6 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-06 | 196 | 83 | 6 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | PND10-Mesenchymal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.81e-06 | 196 | 83 | 6 | ace167a40adb7022b365be3c2b1cbd4ba963739a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-06 | 196 | 83 | 6 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.81e-06 | 196 | 83 | 6 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.81e-06 | 196 | 83 | 6 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.81e-06 | 196 | 83 | 6 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.86e-06 | 197 | 83 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-06 | 197 | 83 | 6 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.86e-06 | 197 | 83 | 6 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| Computational | Neighborhood of CDH11 | 1.29e-04 | 25 | 43 | 3 | GNF2_CDH11 | |
| Drug | Zinc Sulfate | PTCRA EGFR WNT6 SIPA1L1 SRC ANKIB1 NFXL1 BAZ1B GNAS CR1L MAP3K1 ADAMTSL2 COL1A1 DDX11 | 4.24e-07 | 739 | 83 | 14 | ctd:D019287 |
| Drug | NSC-270916 | 5.48e-07 | 82 | 83 | 6 | CID000002949 | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 6.80e-06 | 193 | 83 | 7 | 4410_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; ssMCF7; HG-U133A | 7.27e-06 | 195 | 83 | 7 | 414_DN | |
| Drug | Pivampicillin [33817-20-8]; Up 200; 8.6uM; HL60; HT_HG-U133A | 7.77e-06 | 197 | 83 | 7 | 2945_UP | |
| Drug | Factor Xiiib | 7.89e-06 | 35 | 83 | 4 | CID000126166 | |
| Drug | Alfaxalone [23930-19-0]; Down 200; 12uM; MCF7; HT_HG-U133A | 8.03e-06 | 198 | 83 | 7 | 5451_DN | |
| Drug | N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE | 1.31e-05 | 2 | 83 | 2 | DB07662 | |
| Drug | PD173952 | 2.06e-05 | 15 | 83 | 3 | CID005328733 | |
| Drug | Sodium, Dietary | 2.53e-05 | 16 | 83 | 3 | ctd:D012982 | |
| Drug | Rgd Peptide | 2.71e-05 | 239 | 83 | 7 | CID000104802 | |
| Drug | AC1MHG1S | 3.93e-05 | 3 | 83 | 2 | CID003025825 | |
| Drug | CI-1033 | 4.20e-05 | 53 | 83 | 4 | CID000156413 | |
| Drug | Maprotiline hydrochloride [10347-81-6]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 7.32e-05 | 192 | 83 | 6 | 3236_UP | |
| Drug | benzamidine | 7.84e-05 | 4 | 83 | 2 | ctd:C032157 | |
| Drug | Collagenase | 7.84e-05 | 4 | 83 | 2 | DB00048 | |
| Drug | EGFR/ErbB2 inhibitor | 7.84e-05 | 4 | 83 | 2 | CID009843206 | |
| Drug | (4-(4'-chloro-2'-fluoro)phenylamino)-6,7-dimethylquinazoline | 7.84e-05 | 4 | 83 | 2 | ctd:C575425 | |
| Drug | DO 897/99; Up 200; 8.2uM; MCF7; HT_HG-U133A | 8.21e-05 | 196 | 83 | 6 | 2877_UP | |
| Drug | PF-00539758-00 [351321-34-1]; Up 200; 10uM; MCF7; HT_HG-U133A | 8.21e-05 | 196 | 83 | 6 | 6416_UP | |
| Drug | Nomifensine maleate [32795-47-4]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 8.44e-05 | 197 | 83 | 6 | 7217_UP | |
| Drug | clofibrate; Down 200; 150uM; MCF7; HG-U133A | 8.44e-05 | 197 | 83 | 6 | 263_DN | |
| Drug | Dexamethasone acetate [1177-87-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 8.44e-05 | 197 | 83 | 6 | 6271_UP | |
| Drug | Norfloxacin [70458-96-7]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 8.44e-05 | 197 | 83 | 6 | 2253_DN | |
| Drug | Ethamivan [304-84-7]; Up 200; 18uM; MCF7; HT_HG-U133A | 8.44e-05 | 197 | 83 | 6 | 2879_UP | |
| Drug | Piretanide [55837-27-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 8.44e-05 | 197 | 83 | 6 | 3567_UP | |
| Drug | Boldine [476-70-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 8.44e-05 | 197 | 83 | 6 | 2804_DN | |
| Drug | Mevalonic-D, L acid lactone [674-26-0]; Up 200; 30.8uM; HL60; HT_HG-U133A | 8.44e-05 | 197 | 83 | 6 | 2718_UP | |
| Drug | Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; MCF7; HT_HG-U133A | 8.44e-05 | 197 | 83 | 6 | 6105_DN | |
| Drug | Zidovudine, AZT [30516-87-1]; Up 200; 15uM; HL60; HG-U133A | 8.68e-05 | 198 | 83 | 6 | 1595_UP | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 8.68e-05 | 198 | 83 | 6 | 6073_DN | |
| Drug | Phenelzine sulfate [156-51-4]; Up 200; 17uM; MCF7; HT_HG-U133A | 8.68e-05 | 198 | 83 | 6 | 2319_UP | |
| Drug | Ciprofibrate [52214-84-3]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 8.92e-05 | 199 | 83 | 6 | 3561_UP | |
| Drug | ponatinib | 1.12e-04 | 68 | 83 | 4 | ctd:C545373 | |
| Drug | 3-quinolinecarbonitrile | 1.30e-04 | 5 | 83 | 2 | CID000093177 | |
| Drug | Saralasin | 1.30e-04 | 5 | 83 | 2 | ctd:D012504 | |
| Disease | Ehlers-Danlos syndrome | 9.86e-07 | 8 | 78 | 3 | cv:C0013720 | |
| Disease | CD209 antigen measurement | 6.33e-06 | 14 | 78 | 3 | EFO_0008077 | |
| Disease | coagulation factor measurement | 1.96e-05 | 20 | 78 | 3 | EFO_0004634 | |
| Disease | EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1 | 2.07e-05 | 3 | 78 | 2 | C4552122 | |
| Disease | chromosome 15q11.2 deletion syndrome (implicated_via_orthology) | 2.07e-05 | 3 | 78 | 2 | DOID:0060393 (implicated_via_orthology) | |
| Disease | Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified | 2.07e-05 | 3 | 78 | 2 | C0220679 | |
| Disease | osteonecrosis (is_marker_for) | 4.12e-05 | 4 | 78 | 2 | DOID:10159 (is_marker_for) | |
| Disease | Heart valve disease | 4.42e-05 | 26 | 78 | 3 | C0018824 | |
| Disease | complement factor H-related protein 2 measurement | 6.18e-05 | 29 | 78 | 3 | EFO_0600055 | |
| Disease | scoliosis (implicated_via_orthology) | 6.86e-05 | 5 | 78 | 2 | DOID:0060249 (implicated_via_orthology) | |
| Disease | Ehlers-Danlos Syndrome | 6.86e-05 | 5 | 78 | 2 | C0013720 | |
| Disease | Complement deficiency disease | 9.16e-05 | 33 | 78 | 3 | C0272242 | |
| Disease | aortic valve disease (implicated_via_orthology) | 1.03e-04 | 6 | 78 | 2 | DOID:62 (implicated_via_orthology) | |
| Disease | blood sedimentation | 1.44e-04 | 7 | 78 | 2 | EFO_0004304 | |
| Disease | Autoimmune Lymphoproliferative Syndrome Type 2B | 1.44e-04 | 7 | 78 | 2 | C1846545 | |
| Disease | Nephronophthisis, familial juvenile | 1.44e-04 | 7 | 78 | 2 | C1855681 | |
| Disease | Rectal Neoplasms | 1.44e-04 | 7 | 78 | 2 | C0034885 | |
| Disease | Bleeding tendency | 1.44e-04 | 7 | 78 | 2 | C1458140 | |
| Disease | Rectal Carcinoma | 1.44e-04 | 7 | 78 | 2 | C0007113 | |
| Disease | Hypertensive disease | 1.51e-04 | 190 | 78 | 5 | C0020538 | |
| Disease | complement factor H-related protein 5 measurement | 1.89e-04 | 42 | 78 | 3 | EFO_0008098 | |
| Disease | Ewings sarcoma | 1.91e-04 | 8 | 78 | 2 | C0553580 | |
| Disease | C3 glomerulopathy | 2.45e-04 | 9 | 78 | 2 | C4087273 | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 2.45e-04 | 9 | 78 | 2 | DOID:13359 (is_implicated_in) | |
| Disease | Autosomal Recessive Polycystic Kidney Disease | 2.45e-04 | 9 | 78 | 2 | C0085548 | |
| Disease | bladder neck obstruction (biomarker_via_orthology) | 2.45e-04 | 9 | 78 | 2 | DOID:13948 (biomarker_via_orthology) | |
| Disease | complement factor H-related protein 4 measurement | 3.00e-04 | 49 | 78 | 3 | EFO_0600091 | |
| Disease | Brain hemorrhage | 3.06e-04 | 10 | 78 | 2 | C0553692 | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 3.18e-04 | 50 | 78 | 3 | DOID:3770 (biomarker_via_orthology) | |
| Disease | cortical surface area measurement, neuroimaging measurement | 3.45e-04 | 227 | 78 | 5 | EFO_0004346, EFO_0010736 | |
| Disease | breast carcinoma | COL5A2 TNFRSF9 EGFR SPRY4 ANKIB1 EWSR1 PLG KLHL18 MAP3K1 COL1A1 | 3.46e-04 | 1019 | 78 | 10 | EFO_0000305 |
| Disease | Nephrosclerosis | 3.74e-04 | 11 | 78 | 2 | C0027719 | |
| Disease | pneumococcal bacteremia | 3.74e-04 | 11 | 78 | 2 | EFO_1001925 | |
| Disease | hemopexin measurement | 3.74e-04 | 11 | 78 | 2 | EFO_0008149 | |
| Disease | Aortic Valve Insufficiency | 3.74e-04 | 11 | 78 | 2 | C0003504 | |
| Disease | systemic scleroderma (is_marker_for) | 3.78e-04 | 53 | 78 | 3 | DOID:418 (is_marker_for) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 3.78e-04 | 53 | 78 | 3 | C4707243 | |
| Disease | complement factor H-related protein 1 measurement | 4.45e-04 | 56 | 78 | 3 | EFO_0600054 | |
| Disease | rheumatic heart disease (biomarker_via_orthology) | 4.48e-04 | 12 | 78 | 2 | DOID:0050827 (biomarker_via_orthology) | |
| Disease | tyrosine-protein kinase receptor Tie-1, soluble measurement | 5.28e-04 | 13 | 78 | 2 | EFO_0008312 | |
| Disease | brain measurement, neuroimaging measurement | 6.34e-04 | 550 | 78 | 7 | EFO_0004346, EFO_0004464 | |
| Disease | Williams-Beuren syndrome (implicated_via_orthology) | 7.08e-04 | 15 | 78 | 2 | DOID:1928 (implicated_via_orthology) | |
| Disease | Blood Coagulation Disorders | 8.08e-04 | 16 | 78 | 2 | C0005779 | |
| Disease | cup-to-disc ratio measurement | 9.81e-04 | 430 | 78 | 6 | EFO_0006939 | |
| Disease | anthropometric measurement | 1.04e-03 | 168 | 78 | 4 | EFO_0004302 | |
| Disease | type 1 diabetes mellitus (biomarker_via_orthology) | 1.15e-03 | 19 | 78 | 2 | DOID:9744 (biomarker_via_orthology) | |
| Disease | otosclerosis | 1.31e-03 | 81 | 78 | 3 | EFO_0004213 | |
| Disease | gastric ulcer | 1.40e-03 | 21 | 78 | 2 | EFO_0009454 | |
| Disease | hair color | 1.42e-03 | 311 | 78 | 5 | EFO_0003924 | |
| Disease | waist-hip ratio | KLLN TNFRSF9 ADAMTS9 RNF185 TRAIP SPRY4 DGKQ LTBP2 MAPKBP1 ADAMTSL3 | 1.43e-03 | 1226 | 78 | 10 | EFO_0004343 |
| Disease | Intrahepatic Cholangiocarcinoma | 1.83e-03 | 24 | 78 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 1.83e-03 | 24 | 78 | 2 | C3805278 | |
| Disease | Left Ventricular Hypertrophy | 1.99e-03 | 25 | 78 | 2 | C0149721 | |
| Disease | Malignant neoplasm of breast | 2.08e-03 | 1074 | 78 | 9 | C0006142 | |
| Disease | Cholangiocarcinoma | 2.15e-03 | 26 | 78 | 2 | C0206698 | |
| Disease | Schizophrenia | 2.30e-03 | 883 | 78 | 8 | C0036341 | |
| Disease | Colorectal Carcinoma | 2.57e-03 | 702 | 78 | 7 | C0009402 | |
| Disease | Liver Cirrhosis | 2.60e-03 | 103 | 78 | 3 | C0023890 | |
| Disease | response to paliperidone, schizophrenia symptom severity measurement | 2.61e-03 | 216 | 78 | 4 | EFO_0007925, EFO_0007927 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LRKQCPSRLNSPAWE | 36 | P84996 | |
| WRTECNQCKAPKPEG | 536 | Q01844 | |
| WQCPACQPATARRNS | 1226 | Q9UIG0 | |
| RCWDQDPKKRPCFLD | 266 | Q8NFD2 | |
| WVRDPRYREDPCKQC | 621 | Q9NWN3 | |
| ELCRLPPSSQACDAW | 346 | P52824 | |
| WCPTPGCDRAVRLTK | 421 | Q9P2G1 | |
| WPEQESRLCNLRPCD | 246 | O95388 | |
| ADCTICFWDIRPQKP | 516 | Q8IWG1 | |
| SRREVCQAVPCPARW | 941 | Q76LX8 | |
| QSCPDWRKDCSNNPV | 171 | P28907 | |
| PQIRKCNEQPCQTRW | 966 | Q8TE59 | |
| WRSCSRAIPQVKCNE | 86 | Q7L576 | |
| CPAQAWCSRSALRAP | 246 | Q6ISU1 | |
| TFECQNPRRCKWTEP | 51 | Q17RY6 | |
| PIPRRCSAKEWSCQL | 296 | Q6ZNB6 | |
| CWQKDRNARPRFPQV | 856 | P54760 | |
| IRRDNCSGQKPLLCW | 126 | Q8N386 | |
| ASQEWSSPKKPQCRR | 106 | Q5VZ46 | |
| QPIACNRRDCPSRWM | 1536 | Q8N6G6 | |
| LWLNCSTNCPRPERG | 51 | Q9UMF0 | |
| RPGNWRTATLCPKTC | 281 | Q02817 | |
| TCRNGQWSEPPKCLD | 191 | P36980 | |
| ERKTCRNPACGPQWE | 676 | Q86TH1 | |
| LAWCRQRNPNPSCAA | 96 | B2CW77 | |
| WRSCSRAIPQVKCNE | 86 | Q96F07 | |
| KPRRRVWSPECCQDP | 941 | Q96FC9 | |
| SNPRPKFEDWLCNKC | 176 | P52756 | |
| RNCQNKPCPVDGSWS | 4576 | Q96RW7 | |
| LTCWCRDPEQRPCFK | 421 | Q13882 | |
| TFCCPESWNERDPIR | 976 | Q9UII4 | |
| QIWPREPCDDVKSQC | 546 | Q8IZE3 | |
| WGPEPRDCVSCRNVS | 516 | P00533 | |
| ESRRPCNRVPCPAQW | 956 | O15072 | |
| PWQACSKPCQGERKR | 886 | Q9P2N4 | |
| PIANCWERCRPMTTA | 311 | O94889 | |
| SKQETRECNWQRCPI | 66 | P13671 | |
| QCQADDRWDPPLAKC | 1951 | P17927 | |
| NRPSQKRPRCCSWCR | 11 | Q9UF56 | |
| NKWEPELPSCSRVCQ | 276 | Q2VPA4 | |
| VRPFDWPCKNNRRCR | 901 | Q2V2M9 | |
| RDIWKPAPCQICVCD | 51 | P05997 | |
| QLVRGACKPECNSWE | 36 | Q30KQ7 | |
| CKDGRWQSLPRCVES | 431 | Q9BXR6 | |
| TCRNKQWSEPPRCLD | 491 | Q9BXR6 | |
| AWSQQCALCPPRSSE | 1616 | Q14767 | |
| KPRSESLWRQCSDCP | 731 | O15068 | |
| CRLNPDSSWAPKRVA | 1171 | O60336 | |
| CERCKDFFQDAPWRP | 306 | A4D0S4 | |
| WEPASCQKSCYRPRT | 56 | Q3LI77 | |
| DRDVWKPEPCQICVC | 41 | P02461 | |
| ERQKAWCCSTLPEPA | 751 | Q5FWF5 | |
| NLSSCVWEQCRPEEP | 71 | Q6UWJ8 | |
| VRKDWCESQPCQSRG | 671 | P82279 | |
| PINKVCRDTLRDWCQ | 91 | Q7Z7J5 | |
| LWKQSQDSRPRPEPC | 461 | A6ND36 | |
| RNREPLICPLCRSKW | 481 | Q13233 | |
| RLNDNPWVCDCRARP | 256 | Q9BZR6 | |
| VFSWEPTPRKNRVCC | 746 | Q5VT97 | |
| EDNPWNCSCDLLPLK | 211 | Q8IW52 | |
| DLMCQCWRKEPEERP | 496 | P12931 | |
| ASPRTLPSCWVCNQE | 171 | Q9C004 | |
| RPCLCLSWEEAQSPA | 36 | Q96BQ3 | |
| CPRDKQWLDCAQGPA | 3091 | A2VEC9 | |
| NRSEDSVRPWTCPKC | 316 | O43166 | |
| KNYCRNPDRELRPWC | 231 | P00747 | |
| NKRWELCDIPRCTTP | 251 | P00747 | |
| PEGQWLCRRCLQSPS | 311 | P55201 | |
| RLQNNSCEPCPTSWL | 156 | Q6UXB4 | |
| EDEEPPPRRWCNTCQ | 646 | Q9ULV3 | |
| DVWKPEPCRICVCDN | 51 | P02452 | |
| VSCWPRKRCFPGSQD | 126 | Q3KNT9 | |
| WASPENPCLINECVR | 2521 | P04275 | |
| PTKARRPSSAQQECW | 371 | A6NK02 | |
| NDQKRGICRPWTNCS | 126 | Q07011 | |
| CALRTCWQKLPPFRE | 231 | Q9Y6F9 | |
| WLETRPNRQVCPVCK | 66 | Q96GF1 | |
| CPEQDRLPQRSWRQK | 31 | Q9Y5Z9 | |
| SNCCEDISRPRKPWQ | 216 | Q8IVQ6 | |
| RPCLCLSWEEAQSPA | 36 | A6NCK2 | |
| CNRPCVWSRLLKPNS | 36 | Q5T742 | |
| PSGWKCARCDLRENL | 206 | Q92995 | |
| ACPQRTCPEWVRNLE | 126 | Q8WXB4 | |
| QWFETAPSRTCPQCR | 36 | Q9BWF2 | |
| EPCNIRDCPARWFTS | 1476 | P82987 |